Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
about
Oral tolerance, an active immunologic process mediated by multiple mechanisms.CD40L in autoimmunity and mucosally induced tolerance.Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cellsAutoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and -3 signaling in glia.Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis.Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells.Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes.Immunomodulation with glatiramer acetate prevents long-term inflammatory pain.
P2860
Q33921576-35F9CB39-4D07-4980-BF29-6919B1F913E9Q34502868-CE5BA915-7E61-4FAD-AFF5-F909338B59FDQ35160777-C188684F-B4C5-44F5-880E-FE15490BF335Q35861182-63BB7050-6699-42B0-9CA1-DA6AADD0FF73Q37120570-4B173598-9D97-4DF6-9517-4C657FD96038Q37589284-73FE1DCA-FC30-4086-9343-3762E97EB03DQ40857962-51169E26-C9FC-4A00-9ED4-BB9B7F4DD570Q43627915-14C9AB6B-BE20-4609-BE03-746B61622156Q46135691-EB48A2B2-D1E9-4A30-B2C5-3AC55F5F3FBFQ46733594-961E9AA8-A611-4326-AAC3-5D66CB6729E1
P2860
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@ast
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@en
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@nl
type
label
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@ast
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@en
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@nl
prefLabel
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@ast
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@en
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@nl
P2860
P356
P1476
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
@en
P2093
H L Weiner
P2860
P304
P356
10.1073/PNAS.96.7.3333
P407
P577
1999-03-01T00:00:00Z